SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others.SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 24, 2022 | Series B | $24M | 2 | OurCrowd | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
OurCrowd | Yes | Series B |
Agricultural Bank of China | — | Series B |